UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity

International journal of molecular sciences, 2022-03, Vol.23 (6), p.3150

2022

Volltextzugriff (PDF)

Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR) Acinetobacter baumannii

Molecules (Basel, Switzerland), 2019-08, Vol.24 (15), p.2820

2019

Volltextzugriff (PDF)

Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins

Antimicrobial agents and chemotherapy, 2019-12, Vol.63 (12)

2019

Volltextzugriff (PDF)

Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU

Journal of translational medicine, 2024-03, Vol.22 (1), p.269-15, Article 269

2024

Volltextzugriff (PDF)

Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity

Frontiers in chemistry, 2022-02, Vol.10, p.798006-798006

2022

Volltextzugriff (PDF)

The Safety Record of Fusidic Acid in Non-US Markets: A Focus on Skin Infections

Clinical infectious diseases, 2011-06, Vol.52 (suppl_7), p.S527-S537

2011

Volltextzugriff (PDF)

The Role of RelMtb-Mediated Adaptation to Stationary Phase in Long-Term Persistence of Mycobacterium tuberculosis in Mice

Proceedings of the National Academy of Sciences - PNAS, 2003-08, Vol.100 (17), p.10026-10031

2003

Volltextzugriff (PDF)

Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs

Frontiers in chemistry, 2019-11, Vol.7, p.753-753

2019

Volltextzugriff (PDF)

Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo

Frontiers in chemistry, 2018-08, Vol.6, p.309-309

2018

Volltextzugriff (PDF)

Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development

Frontiers in chemistry, 2018-08, Vol.6, p.359-359

2018

Volltextzugriff (PDF)

Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model

Antimicrobial agents and chemotherapy, 2015-05, Vol.59 (5), p.2525-2530

2015

Volltextzugriff (PDF)

Clinical implications of patient-provider agreements in opioid prescribing

Current drug safety, 2015-01, Vol.10 (2), p.159-164

2015

Volltextzugriff (PDF)

Low hanging fruit in infectious disease drug development

Current opinion in microbiology, 2008-10, Vol.11 (5), p.434-438

Kraus, Carl N

2008

Volltextzugriff (PDF)

Glanders in a Military Research Microbiologist

The New England journal of medicine, 2001-07, Vol.345 (4), p.256-258

2001

Volltextzugriff (PDF)

Inhibition of Mycobacterium tuberculosis AhpD, an Element of the Peroxiredoxin Defense against Oxidative Stress

Antimicrobial Agents and Chemotherapy, 2004-07, Vol.48 (7), p.2424-2430

2004

Volltextzugriff (PDF)

Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education

Current drug safety, 2013-02, Vol.8 (1), p.11-16

2013

Volltextzugriff (PDF)

The practicing clinician and regulatory safety concerns

Current drug safety, 2013-02, Vol.8 (1), p.17-24

2013

Volltextzugriff (PDF)

CRAFT: Facilitating clinical trial execution quality

AMIA ... Annual Symposium proceedings, 2007-10, p.1016-1016

2007

Volltextzugriff (PDF)

Levofloxacin and Macrolides for Treatment of Legionnaires Disease: Multiple Comparisons Give Few Answers

Clinical infectious diseases, 2005-08, Vol.41 (3), p.416-416

2005

Volltextzugriff (PDF)

The Safety Record of Fusidic Acid in Non-US Markets: A Focus on Skin Infections: Fusidic Acid Enters the United States

Clinical infectious diseases, 2011, Vol.52

2011

Volltextzugriff (PDF)

Levofloxacin and Macrolides for Treatment of Legionnaires Disease: Multiple Comparisons Give Few Answers/Reply to Kraus et al

Clinical infectious diseases, 2005-08, Vol.41 (3), p.416

2005

Volltextzugriff (PDF)

The role of Rel Mtb -mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice

Proceedings of the National Academy of Sciences - PNAS, 2003-08, Vol.100 (17), p.10026-10031

2003

Volltextzugriff (PDF)

Direct in vivo evidence of activated macrophages in human osteoarthritis

Osteoarthritis and cartilage, 2016-09, Vol.24 (9), p.1613-1621

2016

Volltextzugriff (PDF)

Soluble Macrophage Biomarkers Indicate Inflammatory Phenotypes in Patients With Knee Osteoarthritis

Arthritis & rheumatology (Hoboken, N.J.), 2015-04, Vol.67 (4), p.956-965

2015

Volltextzugriff (PDF)

TESS Hunt for Young and Maturing Exoplanets (THYME). II. A 17 Myr Old Transiting Hot Jupiter in the Sco-Cen Association

The Astronomical journal, 2020-07, Vol.160 (1), p.33

2020

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(52)
Deutsch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity

Efficacy of ARV-1502, a Proline-Rich Antimicrobial Peptide, in a Murine Model of Bacteremia Caused by Multi-Drug Resistant (MDR) Acinetobacter baumannii

Safety and Pharmacokinetics of a Four Monoclonal Antibody Combination Against Botulinum C and D Neurotoxins

Bacterial DnaK reduces the activity of anti-cancer drugs cisplatin and 5FU

Functional Effects of ARV-1502 Analogs Against Bacterial Hsp70 and Implications for Antimicrobial Activity

The Safety Record of Fusidic Acid in Non-US Markets: A Focus on Skin Infections

The Role of RelMtb-Mediated Adaptation to Stationary Phase in Long-Term Persistence of Mycobacterium tuberculosis in Mice

Quantitation of a Novel Engineered Anti-infective Host Defense Peptide, ARV-1502: Pharmacokinetic Study of Different Doses in Rats and Dogs

Synergy Between Proline-Rich Antimicrobial Peptides and Small Molecule Antibiotics Against Selected Gram-Negative Pathogens in vitro and in vivo

Advantage of a Narrow Spectrum Host Defense (Antimicrobial) Peptide Over a Broad Spectrum Analog in Preclinical Drug Development

Ambush of Clostridium difficile spores by ramoplanin: activity in an in vitro model

Clinical implications of patient-provider agreements in opioid prescribing

Low hanging fruit in infectious disease drug development

Glanders in a Military Research Microbiologist

Inhibition of Mycobacterium tuberculosis AhpD, an Element of the Peroxiredoxin Defense against Oxidative Stress

Improving the effect of FDA-mandated drug safety alerts with Internet-based continuing medical education

The practicing clinician and regulatory safety concerns

CRAFT: Facilitating clinical trial execution quality

Levofloxacin and Macrolides for Treatment of Legionnaires Disease: Multiple Comparisons Give Few Answers

The Safety Record of Fusidic Acid in Non-US Markets: A Focus on Skin Infections: Fusidic Acid Enters the United States

Levofloxacin and Macrolides for Treatment of Legionnaires Disease: Multiple Comparisons Give Few Answers/Reply to Kraus et al

The role of Rel Mtb -mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice

Direct in vivo evidence of activated macrophages in human osteoarthritis

Soluble Macrophage Biomarkers Indicate Inflammatory Phenotypes in Patients With Knee Osteoarthritis

TESS Hunt for Young and Maturing Exoplanets (THYME). II. A 17 Myr Old Transiting Hot Jupiter in the Sco-Cen Association

Suchergebnisse filtern